StockNow
Log in
Global Markets

Dr Reddy's executive says we will be on track to supply between 6-7mln of Novo Nordisk's (NOVOB DC) Semaglutide pens between Q3 and Q4

StockNow breaking-news AI analysis

Dr. Reddy's reported a temporary supply halt for Semaglutide pens until September but maintains its 6-7 million unit H2 supply target, with market resumption expected by late October.

News detail

Issue is nothing to do with whatever we sent to market. Actual supply to market can resume in late October to early November if issue resolved. There will be halt of supply between now and September. We got to know about the issue on Wednesday

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday